News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Let’s hope that all liposarcoma patients and their doctors will hear all about the clinical trial Brightline – Kathi Apostolidis
Photo from Boehringer Ingelheim/Linkedin
Jul 16, 2023, 07:02

Let’s hope that all liposarcoma patients and their doctors will hear all about the clinical trial Brightline – Kathi Apostolidis

This is encouraging news for patients with a very rare cancer, liposarcoma, who had not any new treatment for the last 45years. Let’s hope that all liposarcoma patients and their doctors will hear all about the clinical trial Brightline and get all needed information. 
For details: Click here
Source:
cancer care clinical trial Kathi Apostolidis liposarcoma OncoDaily Oncology rare cancer
Special Coverage
History
Nov 2, 2024, 08:54
Paper Alert! Geographic Variations and Risk Factors in Lung Cancer Incidence
Blog
Nov 2, 2024, 05:07
Razelle Kurzrock: Expanding HER2 horizons - Implications for NSCLC and beyond
Blog
Nov 2, 2024, 03:33
More and more women are living longer with metastatic breast cancer - Africa Cancer Foundation
Blog
Nov 2, 2024, 03:30
Launch of the Africa Breast Cancer Council - Roche Africa
Blog
Nov 2, 2024, 03:27
Dana-Farber’s IBC Annual Patient Forum on Nov 9
Blog
Nov 2, 2024, 03:25
Chemotherapy Outcomes in Pregnant Breast Cancer Patients - ACS Journal Cancer
Blog
Nov 2, 2024, 03:21
Tracey O’Brien: Opening Address at Kids Cancer Alliance Conference
Blog
Nov 2, 2024, 03:18
Matthias Guckenberger: Is SBRT the New Standard of Care for Prostate Cancer?
Blog
Nov 2, 2024, 03:16
Françoise Meunier: Protecting survivors from financial discrimination
Blog
Nov 2, 2024, 03:14
Ruben Mesa: Celebrating New Professors at Wake Forest University School of Medicine
Blog
Nov 2, 2024, 03:06
In the new episode of Lung Cancer Considered, host Stephen Liu previews the upcoming HTTR24 - IASLC
Blog
Nov 2, 2024, 03:04
Melvin LK Chua: Potential Increased Risks of Toxicities with Combo IO Immunotherapy and RT